Duplikium

DuplikiumDuplikium
Duplikium

Duplikium

Cloud-based trade copier for MT4, MT5, cTrader, and more, enabling real-time trade replication across multiple accounts.

DR 302013Active11Neuchâtel, Switzerland
Rate

About

Duplikium is a cloud-based trade copier developed by Swiss banking engineers, founded in 2013. It allows traders to mirror trades across various platforms and brokers with low latency. The service is designed for individuals managing multiple accounts, money managers, and prop firm traders, offering features like multi-master/multi-slave architecture, risk management controls, and cross-platform compatibility.
Frequently asked

What does Duplikium do?

Duplikium is a cloud-based trade copier developed by Swiss banking engineers, founded in 2013. It allows traders to mirror trades across various platforms and brokers with low latency. The service is designed for individuals managing multiple accounts, money managers, and prop firm traders, offering features like multi-master/multi-slave architecture, risk management controls, and cross-platform compatibility.

What is Duplikium's revenue?

StartupHub estimates Duplikium's annual revenue at $1.1M (range $978K to $2.0M, 65% confidence), based on comparable companies in the sector.

Where is Duplikium headquartered?

Duplikium is headquartered in Neuchâtel, Switzerland.

When was Duplikium founded?

Duplikium was founded in 2013.

What industry does Duplikium operate in?

Duplikium operates in Fintech, Trading Software, Forex Trading, Copy Trading, Mirror Trading, Algorithmic Trading.

How many employees does Duplikium have?

Duplikium has approximately 11 people on record.

HEADCOUNT
11
DOMAIN RATING
30
New entrants in Trading Software
Last 90 days
1
New entrants
0.3
Per month
0.1
Per week

An entrant is a company tagged Trading Software whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Comments

No comments yet. Be the first to share your take.